Breast cancer patients exhibiting subtypes C1, C2, C4, and C6 were shown to have elevated expression levels of ALG3, suggesting that ALG3 may have a role in promoting the growth of tumors (Figure 5C). This evidence concerns the gene ALG3 and breast cancer.